Gynecology
Latest News
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Study results suggest that estrogen therapy “is safe in individuals with HR-negative tumors and in those concurrently treated with tamoxifen.”
Latest News
Ob.Gyns. Can Help Patients Manage Weight With Anti-Obesity Medications
Women are especially at risk for weight gain from pregnancy and menopause, so knowing how to treat obesity with medications can be helpful to ob....
Conference Coverage
ART Safe for Breast Cancer Survivors with BRCA1/2 Mutations
Researchers compare maternal and fetal outcomes between those who conceived spontaneously versus those using ART in this high-risk population
Latest News
Clinicians Call for Easing FDA Warnings on Low-Dose Estrogen
He is doing so at a time of increased interest in understanding genitourinary syndrome of menopause, which low-dose estrogen may treat.
From the Journals
Hypofractionated Radiotherapy Limits Toxic Effects in Cervical Cancer
Researchers analyze outcomes from patients undergoing hypofractionated IMRT for cervical cancer after radical hysterectomy and pelvic lymph node...
Latest News
US Researchers Call for Robust Studies Into Dequalinium, a Bacterial Vaginosis Therapy Common in Europe
The product is an antiseptic that inhibits the growth of bacteria and fungi and is on par with or better than treatments currently available.
News
FDA Approves New Antibiotic for Uncomplicated UTIs
Pivmecillinam is intended to treat UTIs caused by susceptible isolates of Escherichia coli, Proteus...
Conference Coverage
Ovarian Cancer: Another Promising Target for Liquid Biopsy
A test under development “looks very sensitive for detecting ovarian cancer early.”
Latest News
Surgeon Claims Colleague Made False Board Complaints to Get Him Fired
Kaiser Permanente surgeon claims colleague made claims within the hospital and to medical board that harmed his reputation.
Conference Coverage
Minimally Invasive Cytoreductive Approach Comparable to Open Surgery for Ovarian Cancer
There were no differences in survival for patients with complete gross resections who underwent interval debulking via laparoscopy/robotics or...
Conference Coverage
Therapeutic HPV16 vaccine clears virus in most patients with CIN
An experimental vaccine delivered by electroporation cleared virus in 78% of women with CIN2/3 by 6 months.